“Rivaroxaban was clearly beneficial in patients with chronic kidney disease and was particularly effective at reducing the risk of limb events in patients — that is, acute limb ischemia and above-the-knee amputation,” Judith Hsia, MD, with the department of medicine at University of Colorado School of Medicine, told Healio.